Taylor Swift
Advertisement
Supported by
The movie made an estimated $95 million in ticket sales in the U.S. and Canada, giving a big boost to theaters suffering from strike-related delays.
While she wasn’t able to hit the astronomical heights predicted for her concert film, Taylor Swift is still the current hero of the movie business.
The world’s biggest pop star has easily won the weekend box office with her concert film “Taylor Swift: The Eras Tour,” with an estimated three-day gross of $95 million to $97 million in North American theaters.
The PG-13-rated film, with a close to three-hour run time, has given Swifties and non-Swifties, young and old, a reason to return to the movie theaters at a time when theaters need it most. The ongoing actor’s strike prompted studios to postpone six major fall releases like “Dune: Part Two” and Sony’s “Ghostbusters: Afterlife” sequel, a loss that analysts predict could cost the movie business $1.6 billion in worldwide box office receipts.
And the box office in North America is still recovering from its prepandemic heights, down about 17 percent from 2019 when 16 more films were released in theaters.
The Taylor Swift film, which cost around $15 million to make, opened in 3,855 theaters in the United States and Canada. (Ms. Swift added a preview night of screenings on Thursday in 2,700 theaters to accommodate the seemingly insatiable demand for everything Taylor. Those showings grossed $2.8 million.)
The film earned an additional estimated $31 million to $33 million across 94 international territories in over 4,500 theaters, putting its global receipts at $126 million to $130 million. It will expand to additional international locations in the coming weeks.
We are having trouble retrieving the article content.
Please enable JavaScript in your browser settings.
Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.
Thank you for your patience while we verify access.
Already a subscriber? Log in.
Want all of The Times? Subscribe.
Advertisement
